Persistent Systems Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/tddr2qnyi472tnyls5guzsa9.pdf

Key Takeaways


Demand Environment

Kalra: "if you were to look at it, Sucrit, the data, cloud, digital engineering, that's exactly where we are investing."

AI Platform Monetization & Margin Mechanics

Margin walk (QoQ)Impact
Annual wage hike–180 bps
New Labour Code provisioning (one-time)–230 bps
AI-driven engagement margins+150 bps
Currency tailwind+30 bps
Lower subcontractor cost+20 bps
Operational efficiencies+40 bps
Net change → 14.4%–190 bps
Kalra: "We are not aspiring now to take it another 200 basis points up. We are happy where we are reaching. And I think we have proven to the world we can achieve the margins we have to. And we should put this to rest, make sure that we are a growth engine for the time being."

Deal Wins & Order Book

A $100 mn TCV cybersecurity deal with a Tier-I US bank headlined the quarter, alongside a $50 mn-plus pathology and laboratory automation engagement. The pipeline shows breadth across verticals and a growing share of platform-led, IP-heavy wins.

DealDetails
Tier-I US bankSelected Persistent for a cybersecurity transformation program; $100 mn TCV with a 25% new-TCV component.
US pathology/lab professional organizationEnd-to-end technology partner in a $50 mn-plus, five-year engagement, one of the largest deals in the pathology and laboratory automation domain.
Next-Gen Manufacturing & Supply Chain leader360-degree partnership across engineering, Cloud operations, professional services, and go-to-market collaboration.
Global materials purity/semiconductor leaderFirst-of-its-kind strategic win in materials science to modernize R&D architecture.
Global fintech and insurance firmStrategic partner to modernize acquired platforms.
French multinational bankData platform migration and modernization.
Global kidney/vital organ therapy leaderModernize and manage IT infrastructure.
Patient support services providerFirst significant win in Salesforce Life Sciences Cloud domain, integrating CRM and modernizing data platforms.

Platform & IP Strategy

Teredesai: "the growth in these intangibles will not be at the same level as what you have seen in the past."

People, Productivity & Operating Model

Kalra: "Using our platforms, we are able to get to 60 to 70% of reverse engineering of business logic, convert that to even an English document so that the business users can understand."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue aspiration$2 bn revenue run-rateBy March 2027
Revenue aspiration$5 bn revenue run-rateBy March 2031
Effective Tax Rate20%–24% range for FY26FY26 (full year)
Labour Code provisioningAligned with New Labour Codes going forwardOngoing from Q3 FY26
ESOP costFurther reductionFY27
Intangible asset growthGrowth rate will decelerate from past levelsOngoing
Dividend payoutConsistent payout ratio maintainedOngoing

Key Metrics

MetricQ3 FY26
Revenue$422.5 million, +4.0% QoQ and +17.3% YoY
Revenue (₹)₹3,778.21 crore, +5.5% QoQ and +23.4% YoY
Constant currency revenue growth4.1% QoQ
EBIT margin14.4%, down 50 bps YoY; includes 230 bps one-time labour code impact
EBIT margin excluding one-time labour code impact16.7%, a 40 bps improvement over Q2 FY26
EBIT₹542.75 crore, +19.1% YoY
PAT margin11.6%, down 6.8% QoQ and up 17.8% YoY in absolute terms
PAT₹439.45 crore, +17.8% YoY
PAT margin excluding one-time labour code impact13.4%, +35.7% YoY
Earnings Per Share₹28.20, +16% YoY
Total Contract Value (TCV) of bookings$674.5 million, with new bookings TCV of $369.1 million
Annual Contract Value (ACV) of bookings$501.9 million, with new bookings ACV of $255.8 million
BFSI vertical revenue growth29.3% YoY in USD
Software, Hi-Tech and Emerging Industries revenue growth14.7% YoY in USD
Healthcare, Life Sciences revenue growth7.4% YoY in USD
North America revenue growth18.6% YoY in USD
Europe revenue growth22.0% YoY in USD
Total headcount26,711, an increase of 487 QoQ
Trailing Twelve Months attrition13.5%, improved from 13.8% in Q2 FY26
Billed DSO57 days, up 3 days QoQ
Operating Cash Flow to PAT91%, compared to 114.3% in Q2 FY26
Return on Capital Employed (ex-cash)43.8%, compared to 45.5% in Q2 FY26
Interim dividend₹22 per share, up from ₹20 per share in the prior year
Effective Tax Rate22.2%, FY26 guidance range of 20%–24%
Forward contracts outstanding$490 million at an average rate of ₹89.1/dollar
Total cash and investments₹2,904.65 crore as of December 31, 2025
S&P Global ESG score86, improved from 85 last year